Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.87B |
| 2 |
NVIDIA
NVDA
|
+$2.46B |
| 3 |
Microsoft
MSFT
|
+$1.32B |
| 4 |
Amazon
AMZN
|
+$1.13B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.78B |
| 2 |
SNDK
Sandisk
SNDK
|
+$949M |
| 3 |
Advanced Micro Devices
AMD
|
+$926M |
| 4 |
Micron Technology
MU
|
+$585M |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
+$509M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Communication Services | 0.62% |
| 3 | Consumer Discretionary | 0.62% |
| 4 | Industrials | 0.48% |
| 5 | Healthcare | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13151
Hongli Group
HLP
$88.2M
| $8.63K | ﹤0.01% |
+18,761
| New | +$13.8K |
|
13152
CBAK Energy Technology Ltd
CBAT
$73M
| $8.62K | ﹤0.01% |
14,568
-12,609
| -46% | -$9.64K |
|
13153
Lexaria Bioscience
LEXX
$18M
| $8.55K | ﹤0.01% |
+1,018
| New | +$11K |
|
13154
Moving iMage Technologies
MITQ
$5.37M
| $8.53K | ﹤0.01% |
+14,713
| New | +$8.83K |
|
13155
AtlasClear
ATCH
$29.3M
| $8.46K | ﹤0.01% |
+43,008
| New | +$10.3K |
|
|
INEO
13156
INNEOVA Holdings Ltd
INEO
$8.39M
| $8.43K | ﹤0.01% |
+12,578
| New | +$7.45K |
|
13157
IT Tech Packaging
ITP
$3.04M
| $8.33K | ﹤0.01% |
+45,042
| New | +$8.8K |
|
|
OFAL
13158
OFA Group
OFAL
$2.01M
| $8.19K | ﹤0.01% |
+4,390
| New | +$20.5K |
|
13159
GEE Group
JOB
$27M
| $7.98K | ﹤0.01% |
+38,016
| New | +$8.86K |
|
|
CYAB
13160
Cyabra Inc
CYAB
$5.25M
| $7.98K | ﹤0.01% |
+20,362
| New | +$16.9K |
|
13161
IGC Pharma
IGC
$31.8M
| $7.86K | ﹤0.01% |
28,882
-93,713
| -76% | -$27.7K |
|
|
ELBM
13162
Electra Battery Materials
ELBM
$67.2M
| $7.66K | ﹤0.01% |
+12,687
| New | +$7.78K |
|
13163
Snail Inc
SNAL
$25.5M
| $7.57K | ﹤0.01% |
2,441
-4,980
| -67% | -$18.1K |
|
|
YHC
13164
LQR House Inc
YHC
$2.31M
| $7.5K | ﹤0.01% |
+950
| New | +$83.3K |
|
13165
Cheche Group
CCG
$40.4M
| $7.35K | ﹤0.01% |
+390
| New | +$8.36K |
|
13166
CALL
CXApp
CXAI
$9M
| $7.28K | ﹤0.01% |
+766
| New | +$7.05K |
|
13167
Citius Pharmaceuticals
CTXR
$16.5M
| $7.13K | ﹤0.01% |
11,795
-25,043
| -68% | -$17K |
|
|
TNMG
13168
TNL Mediagene
TNMG
$1.17M
| $6.9K | ﹤0.01% |
+10,627
| New | +$9.65K |
|
|
OBAI
13169
Our Bond Inc
OBAI
$10.7M
| $6.82K | ﹤0.01% |
+10,561
| New | +$7.33K |
|
|
BGLWW
13170
Blue Gold Ltd Warrant
BGLWW
$345K
| $6.7K | ﹤0.01% |
+55,842
| New | +$12K |
|
13171
SHF Holdings
SHFS
$2.03M
| $6.67K | ﹤0.01% |
+27,794
| New | +$15.5K |
|
|
FTRK
13172
DELISTED
Fast Track Group
FTRK
| $6.36K | ﹤0.01% |
14,287
-20,132
| -58% | -$8.52K |
|
|
AIM
13173
AIM ImmunoTech
AIM
$7.87M
| $6.21K | ﹤0.01% |
+21,859
| New | +$9.99K |
|
13174
Solid Power Inc Warrant
SLDPW
$6.93M
| $6.18K | ﹤0.01% |
60,461
+46,057
| +320% | +$9.77K |
|
13175
BioRestorative Therapies
BRTX
$5.49M
| $6.04K | ﹤0.01% |
+16,068
| New | +$4.7K |
|
Similar funds
Jeff Yass's Q2 2026 Portfolio in Review
As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $142B of net new capital in Q2 2026, opening 1,956 new positions and adding to 5,793 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 2% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.78B trimmed.
- Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
- Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
- Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
- Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
- Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
- Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.